search
Back to results

Repeated Bout Effect i Neuromuscular Diseases

Primary Purpose

Myopathy

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Exercise
Sponsored by
Mads Peter Godtfeldt Stemmerik
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Myopathy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age > 18 years The ability to complete the exercise challenge No concurrent medical condition that could interfere with interpretation of the results Molecular diagnosis of the specific condition in specified patient groups or healthy control No active muscle injury on the test day (caused by recent exercise, seizures, trauma, etc.) Exclusion Criteria: Cardiac or pulmonary disease contraindicating peak exercise testing or strenuous exercise defined as NYHA-class III-IV Veins that are too difficult to puncture for blood sampling, evaluated by the investigator Severe muscle weakness, that prevents the subject completing the exercise test, evaluated by the investigator

Sites / Locations

  • Neuromuscular Research Unit, 3342Recruiting

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Exercise challenge

Arm Description

At baseline, subjects will perform the selected exercise challenge followed by blood samples collected at rest and 0, 2, 4, 24 hours and 4 days after end of exercise. Muscle soreness will be measured by asking the participant how sore their muscles in their thighs are on a visual-analog scale (1-10) at the same timepoints. After 4 weeks (+/- 3 days) of normal daily activity, the same test will be performed including blood samples.

Outcomes

Primary Outcome Measures

Delta CK
Change in peak kreatine kinase following first and second exercise bout.

Secondary Outcome Measures

Full Information

First Posted
October 26, 2022
Last Updated
April 3, 2023
Sponsor
Mads Peter Godtfeldt Stemmerik
search

1. Study Identification

Unique Protocol Identification Number
NCT05599568
Brief Title
Repeated Bout Effect i Neuromuscular Diseases
Official Title
Repeated Bout Effect i Neuromuscular Diseases
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 15, 2022 (Actual)
Primary Completion Date
January 1, 2024 (Anticipated)
Study Completion Date
May 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Mads Peter Godtfeldt Stemmerik

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The repeated bout effect (RBE) refers to the adaptation whereby a single bout of eccentric exercise protects against muscle damage from subsequent eccentric bouts. This effect has been shown in many muscle groups using both serum biomarkers, muscle soreness and imaging techniques. Though the effect is well described in healthy, it has never been studied in patients with neuromuscular diseases (NMDs). In healthy, the RBE is only described using eccentric exercise, but unlike healthy persons, patients with NMDs can experience significant muscle damage with concentric exercise. This raises the question, if patients with NMDs could also show RBE when performing concentric exercise.
Detailed Description
The repeated bout effect (RBE) refers to the adaptation whereby a single bout of eccentric exercise protects against muscle damage from subsequent eccentric bouts. This effect has been shown in many muscle groups using both serum biomarkers, muscle soreness and imaging techniques. Though the effect is well described in healthy, it has never been studied in patients with neuromuscular diseases (NMDs). NMDs are a common term for diseases that affect the muscles by disease processes in the motor neuron, peripheral nerve, neuromuscular junction or the muscles. The diseases can cause symptoms such as muscle weakness, muscle fatigue and sometimes muscle pain and varying degrees of physical disability. As the mechanisms for disease varies among NMDs, it is likely that some patients will experience RBE in a similar fashion to healthy, while others may not. Recent years have shown significant breakthrough in the treatment development for various NMDs, and many of these treatments are currently or will soon be evaluated in clinical trials. As many trials will use exercise to evaluate treatment effect, it is vital to understand whether a single bout of exercise in itself provides a protective effect on the muscles of patients with NMDs. In healthy, the RBE is only described using eccentric exercise, but unlike healthy persons, patients with NMDs can experience significant muscle damage with concentric exercise. This raises the question, if patients with NMDs could also show RBE when performing concentric exercise.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopathy

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Exercise challenge
Arm Type
Other
Arm Description
At baseline, subjects will perform the selected exercise challenge followed by blood samples collected at rest and 0, 2, 4, 24 hours and 4 days after end of exercise. Muscle soreness will be measured by asking the participant how sore their muscles in their thighs are on a visual-analog scale (1-10) at the same timepoints. After 4 weeks (+/- 3 days) of normal daily activity, the same test will be performed including blood samples.
Intervention Type
Other
Intervention Name(s)
Exercise
Intervention Description
Either concentric or excentric exercise
Primary Outcome Measure Information:
Title
Delta CK
Description
Change in peak kreatine kinase following first and second exercise bout.
Time Frame
1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > 18 years The ability to complete the exercise challenge No concurrent medical condition that could interfere with interpretation of the results Molecular diagnosis of the specific condition in specified patient groups or healthy control No active muscle injury on the test day (caused by recent exercise, seizures, trauma, etc.) Exclusion Criteria: Cardiac or pulmonary disease contraindicating peak exercise testing or strenuous exercise defined as NYHA-class III-IV Veins that are too difficult to puncture for blood sampling, evaluated by the investigator Severe muscle weakness, that prevents the subject completing the exercise test, evaluated by the investigator
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mads Stemmerik, MD
Phone
+4535456126
Email
mads.peter.godtfeldt.stemmerik@regionh.dk
Facility Information:
Facility Name
Neuromuscular Research Unit, 3342
City
Copenhagen
ZIP/Postal Code
DK-2100
Country
Denmark
Individual Site Status
Recruiting

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Repeated Bout Effect i Neuromuscular Diseases

We'll reach out to this number within 24 hrs